Smith & Nephew (NYSE:SNN) Rating Lowered to “Hold” at Berenberg Bank

Berenberg Bank downgraded shares of Smith & Nephew (NYSE:SNN) from a buy rating to a hold rating in a report released on Wednesday, Marketbeat.com reports.

Several other analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Smith & Nephew Price Performance

Shares of SNN stock opened at $24.29 on Wednesday. Smith & Nephew has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. The stock has a 50 day simple moving average of $29.37 and a two-hundred day simple moving average of $27.82.

Hedge Funds Weigh In On Smith & Nephew

A number of large investors have recently modified their holdings of the company. Janney Montgomery Scott LLC lifted its stake in shares of Smith & Nephew by 13.8% in the first quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock valued at $244,000 after buying an additional 1,165 shares in the last quarter. Inspire Advisors LLC lifted its position in Smith & Nephew by 4.7% in the 1st quarter. Inspire Advisors LLC now owns 21,647 shares of the medical equipment provider’s stock valued at $549,000 after acquiring an additional 970 shares in the last quarter. Headlands Technologies LLC boosted its stake in Smith & Nephew by 225.0% during the 1st quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock valued at $98,000 after purchasing an additional 2,666 shares during the last quarter. QRG Capital Management Inc. increased its holdings in Smith & Nephew by 47.0% during the 1st quarter. QRG Capital Management Inc. now owns 93,034 shares of the medical equipment provider’s stock worth $2,359,000 after purchasing an additional 29,754 shares in the last quarter. Finally, Henry James International Management Inc. raised its stake in shares of Smith & Nephew by 12.2% in the first quarter. Henry James International Management Inc. now owns 205,417 shares of the medical equipment provider’s stock worth $5,209,000 after purchasing an additional 22,341 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.